Latest News and Press Releases
Want to stay updated on the latest news?
-
SPOKANE, Wash., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Avista has selected projects as part of its request for proposal (RFP) process to identify new resources to support long-term reliability and...
-
Fourth Quarter 2025 Highlights GAAP Net Income of $15.0 million was flat compared to 3Q 2025. Earnings per share of $0.91 increased $0.02 per share, compared to 3Q 2025 and return on average assets...
-
NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced a 15-year extension of its exclusive worldwide license agreement...
-
GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on...
-
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and...
-
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
-
TORONTO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- (TSX: BBBB, KNGC, KNGU, KNGX) – On December 17, 2025, Brompton Funds announced special year end estimated distributions for Brompton Wellington Square...
-
Aventura, FL, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Employers spent 2025 navigating a variety of challenges, not the least of which were heavy economic pressure and high cost sensitivity. As a result,...
-
WATERTOWN, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation...
-
Art Technology Acquisition Corp. Announces the Closing of Full Exercise of IPO Over-Allotment Option
PHILADELPHIA, PA, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Art Technology Acquisition Corp. (NASDAQ:ARTCU) (the “Company”) today announced that the underwriter of its previously announced initial public...